News | News By Subject | News by Disease News By Date | Search News

Allergies (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
BioPharm Executive: Ok, So It's Hillary     10/28/2016
5 Myths About Mylan (MYL)'s EpiPen Scandal     9/9/2016
Backlash Leads Mylan (MYL) to Launch First Generic EpiPen at Half the Price     8/29/2016
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen     8/26/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400%     8/24/2016
Merck & Co. (MRK) to Terminate Allergy Agreement With ALK-Abello A/S     7/27/2016
Allergy Therapeutics Phase II Fails to Find Hay Fever Therapy Dose Range     6/27/2016
Circassia (CIR.L) Stock Crashes as Allergy Drug Flunks Crucial Phase III Study     6/20/2016
Ocular Therapeutix (OCUL)'s Pink Eye Treatment Dextenza Flunks Phase III Test     6/6/2016
Rubius Therapeutics Springs Out of Flagship VentureLabs to Take on PKU with Red Cell Therapeutics     12/9/2015
Sanofi (SNY) May Suffer a $109 Million Hit from Injector Recall     10/29/2015
Astellas (ALPMY), Immunomic Forge $300 Million+ LAMP-vax Pact     10/9/2015
DBV Tech Nabs FDA Breakthrough Status for Peanut Allergy Patch     4/13/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application     4/1/2015
GlaxoSmithKline (GSK) Down Slightly After Johnson & Johnson (JNJ) Allergy Ad Settlement     3/31/2015

News from Around the Web
Mylan (MYL) Expands EpiPen Recall To The U.S.     4/3/2017
Mylan (MYL) Recalls 81,000 EpiPens Overseas After Reports of Failure     3/23/2017
Mylan (MYL) Faces Federal Antitrust Investigator In EpiPen Business     1/31/2017
Mylan (MYL) CEO Hopes EpiPen Furor Leads To "Price Transparency"     12/5/2016
Mylan (MYL) CEO Bresch Admits "Full Responsibility" For EpiPen Price Hikes     12/2/2016
Are Food Allergies On The Rise? Experts Say They Don't Know     12/1/2016
Meet The Woman Who Is Allergic To Everything - Including Her Husband     11/21/2016
A Pill May Soon Replace Mylan (MYL)'s Costly EpiPen     11/21/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
There's A Patch That Could Fix Your Peanut Allergy Problem, DBV Tech Reveals     11/2/2016
The First Peanut Allergy Therapy Might Soon Hit The Shelves, DBV Tech Reveals     10/26/2016
Health Officials Should Reject Latest Gambit By EpiPen Maker To Feed At The Public Trough     10/18/2016
Mylan (MYL) Stock Rises -- Is There A Light At The End Of The Tunnel?     10/11/2016
Mylan (MYL) CEO to be Grilled by Congress Over EpiPen Pricing     9/15/2016
Biotech CEOs: Please Don't Let EpiPen Threaten Innovation     9/13/2016

Press Releases
Circassia (CIR.L) Finally Throws In The Towel On Allergy Program After Trial Failures     4/18/2017
Sanofi (SNY) Announces Results Of First-Of-Its-Kind Social Experiment Revealing Real-Life Impact Of Symptoms On Allergy Sufferers In The U.S.     3/21/2017
DBV Tech Announces Completion Of Enrollment Of The REALISE Study In Peanut Allergic Children     3/10/2017
NicOx SA (COX.PA) Resubmits AC-170 (ZERVIATE) NDA To The FDA     3/9/2017
Aimmune (AIMT) To Release Fourth Quarter And Full Year 2016 Financial Results On Wednesday, March 15, 2017     3/8/2017
Aimmune (AIMT) Presents Clinical Data On Phase III Screening And Phase 2 Adherence For AR101 For Peanut Allergy At The 2017 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting     3/6/2017
DBV Tech Release: Data At AAAAI 2017 Show Lasting Response And Favorable Safety Profile Of Investigational Agent, Viaskin Peanut, Throughout Three Years Of Treatment Of Peanut Allergic Children     3/6/2017
ALK-Abello A/S's ACARIZAX Data Results In Significant Change To The GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended As A Treatment Option In Patients With House Dust Mite Allergic Asthma     2/27/2017
Bluejay Diagnostics, Inc. Announces Clinical Research Collaboration To Develop Point Of Care Test For Allergic Conjunctivitis     2/27/2017
Anergis Completes Patient Recruitment In Large-Scale ATIBAR Trial With Ultra-Fast Allergy Immunotherapy AllerT     2/8/2017
GlaxoSmithKline Consumer Healthcare Launches FLONASE Sensimist Allergy Relief Nationwide     2/8/2017
Selecta (SELB) Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine And Celiac Disease Treatment     2/6/2017
Sanofi (SNY)'s Xyzal Allergy 24HR Approved For Over-The-Counter Use In The United States     2/1/2017
OptiNose AS Announces FDA Acceptance For Filing Of The New Drug Application For OPN-375     1/31/2017
Biomay AG Release: Company Reports Positive Results From A Second Phase Ilb Trial With The Innovative 3rd Generation Grass Pollen Allergy Vaccine Bm32     1/26/2017